These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2852438)

  • 21. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain.
    Widdowson PS; Halaris AE
    Brain Res; 1991 Jan; 539(2):196-202. PubMed ID: 1647239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin release in the rat brain cortex is inhibited by neuropeptide Y but not affected by ACTH1-24, angiotensin II, bradykinin and delta-sleep-inducing peptide.
    Schlicker E; Gross G; Fink K; Glaser T; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb; 343(2):117-22. PubMed ID: 1648670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex.
    Westlind-Danielsson A; Undén A; Abens J; Andell S; Bartfai T
    Neurosci Lett; 1987 Feb; 74(2):237-42. PubMed ID: 3033554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y modulates neurotransmitter release and Ca2+ currents in rat sensory neurons.
    Walker MW; Ewald DA; Perney TM; Miller RJ
    J Neurosci; 1988 Jul; 8(7):2438-46. PubMed ID: 2907913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY.
    Clark JT; Sahu A; Kalra PS; Balasubramaniam A; Kalra SP
    Regul Pept; 1987 Jan; 17(1):31-9. PubMed ID: 3562905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents.
    Shen GH; Grundemar L; Zukowska-Grojec Z; Håkanson R; Wahlestedt C
    Eur J Pharmacol; 1991 Nov; 204(3):249-56. PubMed ID: 1723049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes.
    Balasubramaniam A; Sheriff S
    J Biol Chem; 1990 Sep; 265(25):14724-7. PubMed ID: 2168390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia.
    Cox HM; Cuthbert AW; Håkanson R; Wahlestedt C
    J Physiol; 1988 Apr; 398():65-80. PubMed ID: 3392683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fourth ventricular neuropeptide Y and peptide YY on ingestive and other behaviors.
    Corp ES; Melville LD; Greenberg D; Gibbs J; Smith GP
    Am J Physiol; 1990 Aug; 259(2 Pt 2):R317-23. PubMed ID: 2386243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of neuropeptides on the release of neurotransmitter amino acids from rat striatum.
    Ellis Y; Davies JA
    Neuropeptides; 1994 Jan; 26(1):65-9. PubMed ID: 7512699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-methyl-D-aspartate receptor complex modulation by neuropeptide Y and peptide YY in rat hippocampus in vitro.
    Roman FJ; Pascaud X; Duffy O; Junien JL
    Neurosci Lett; 1991 Jan; 122(2):202-4. PubMed ID: 1827514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposite effects of neuropeptide Y (NPY) and polypeptide YY (PYY) on plasma immunoreactive atrial natriuretic factor (IR-ANF) in rats.
    Baranowska B; Gutkowska J; Lemire A; Cantin M; Genest J
    Biochem Biophys Res Commun; 1987 Jun; 145(2):680-5. PubMed ID: 2954552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Y selectively inhibits slow synaptic potentials in rat dorsal raphe nucleus in vitro by a presynaptic action.
    Kombian SB; Colmers WF
    J Neurosci; 1992 Mar; 12(3):1086-93. PubMed ID: 1545233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of adenylate cyclase by galanin, neuropeptide Y, secretin and vasoactive intestinal polypeptide in rat frontal cortex, hippocampus and hypothalamus.
    Karelson E; Laasik J; Sillard R
    Neuropeptides; 1995 Jan; 28(1):21-8. PubMed ID: 7538201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of acetylcholine release from guinea pig myenteric neurons by neuropeptide Y: GTP-binding protein mediation.
    Mulholland MW; Jaffer S
    J Surg Res; 1991 Jun; 50(6):574-8. PubMed ID: 1904963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y and galanin in norepinephrine release in hypothalamic slices.
    Tsuda K; Yokoo H; Goldstein M
    Hypertension; 1989 Jul; 14(1):81-6. PubMed ID: 2472359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of receptor antagonists of neuropeptide Y.
    Tatemoto K; Mann MJ; Shimizu M
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1174-8. PubMed ID: 1311083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-alpha-biotinylated-neuropeptide Y analogs: syntheses, cardiovascular properties, and application to cardiac NPY receptor visualization.
    Balasubramaniam A; Sheriff S; Ferguson DG; Stein M; Rigel DF
    Peptides; 1990; 11(6):1151-6. PubMed ID: 1965029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropeptide Y (NPY) and peptide YY (PYY) inhibit prostaglandin E2-induced intestinal fluid and electrolyte secretion in the rat jejunum in vivo.
    Saria A; Beubler E
    Eur J Pharmacol; 1985 Dec; 119(1-2):47-52. PubMed ID: 3866691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide YY and neuropeptide Y induce villin expression, reduce adhesion, and enhance migration in small intestinal cells through the regulation of CD63, matrix metalloproteinase-3, and Cdc42 activity.
    Lee M; Hadi M; Halldén G; Aponte GW
    J Biol Chem; 2005 Jan; 280(1):125-36. PubMed ID: 15504731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.